The Association of Medicare Drug Coverage with Use of Evidence-Based Medications in the Veterans Health Administration

Background: Veterans with Medicare managed-care plans have access to pharmacy benefits outside the Veterans Health Administration (VA), but how this coverage affects use of medications for specific disease conditions within the VA is unclear. Objective: To examine patterns of pharmacotherapy among patients with diabetes mellitus, ischemic heart disease, and chronic heart failure enrolled in fee-for-service (FFS) or managed-care (HMO) plans and to test whether pharmacy benefit coverage within Medicare is associated with the receipt of evidence-based medications in the VA. Methods: A retrospective analysis of veterans dually enrolled in the VA and Medicare healthcare systems was conducted. We used VA and Medicare administrative data from 2002 in multivariable logistic regression analysis to determine the unique association of enrollment in Medicare FFS or managed-care plans on the use of medications, after adjusting for sociodemographic, geographic, and patient clinical factors. Results: A total of 369,697 enrollees met inclusion criteria for diabetes, ischemic heart disease, or chronic heart failure. Among patients with diabetes, adjusted odds ratios (ORs) of receiving angiotensin-converting enzyme (ACE) inhibitors and oral hypoglycemics in the FFS group were, respectively, 0.86 and 0.80 (p < 0.001). Among patients with ischemic heart disease, FFS patients were generally less likely to receive ß-blockers, antianginals, and statins. Among patients with chronic heart failure, adjusted ORs of receiving ACE inhibitors, angtotensin-receptor blockers, and statins in the FFS group were, respectively, 0.90, 0.78, and 0.79 (all p < 0.05). There were few systematic differences within HMO coverage levels. Conclusions: FFS-enrolled veterans were generally less likely to be receiving condition-related medications from the VA, compared with HMO-enrolled veterans with lower levels of prescription drug coverage. Pharmacy prescription coverage within Medicare affects the use of evidence-based medications for specific disease conditions in the VA.

[1]  Michael L. Johnson,et al.  VHA pharmacy use in veterans with Medicare drug coverage. , 2009, The American journal of managed care.

[2]  P. Austin,et al.  Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction , 2008, Canadian Medical Association Journal.

[3]  M. Rubio‐Stipec,et al.  Medication access and continuity: the experiences of dual-eligible psychiatric patients during the first 4 months of the Medicare prescription drug benefit. , 2007, The American journal of psychiatry.

[4]  Michael L. Johnson,et al.  Patterns of antihypertensive therapy among patients with diabetes , 2005, Journal of General Internal Medicine.

[5]  Peter J. Richardson,et al.  Adapting the Rx-Risk-V for Mortality Prediction in Outpatient Populations , 2006, Medical care.

[6]  Beth A Virnig,et al.  Using a Spanish surname match to improve identification of Hispanic women in Medicare administrative data. , 2006, Health services research.

[7]  M. Abrahamson,et al.  Medicare coverage for patients with diabetes. A national plan with individual consequences. , 2006, Journal of general internal medicine.

[8]  A. Hendricks,et al.  VA-Medicare Dual Beneficiaries’ Enrollment in Medicare HMOs: Access to VA, Availability of HMOs, and Favorable Selection , 2005, Medical care research and review : MCRR.

[9]  W. Weeks,et al.  Utilization of VA and Medicare Services by Medicare‐Eligible Veterans: The Impact of Additional Access Points in a Rural Setting , 2005, Journal of healthcare management / American College of Healthcare Executives.

[10]  J. Gums,et al.  Angiotensin Receptor Blockers versus ACE Inhibitors: Prevention of Death and Myocardial Infarction in High-Risk Populations , 2005, The Annals of pharmacotherapy.

[11]  Kenneth Pietz,et al.  Comparison of the Predictive Validity of Diagnosis-Based Risk Adjusters for Clinical Outcomes , 2005, Medical care.

[12]  C. Cowan,et al.  Health spending growth slows in 2003. , 2005, Health affairs.

[13]  B. Virnig,et al.  Improving Identification of Hispanic Males in Medicare: Use of Surname Matching , 2004, Medical care.

[14]  P. Austin,et al.  Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000. , 2004, The American journal of medicine.

[15]  Donald R. Miller,et al.  Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. , 2004, Diabetes care.

[16]  Lisa I. Iezzoni,et al.  Risk Adjustment of Medicare Capitation Payments Using the CMS-HCC Model , 2004, Health care financing review.

[17]  T. Wagner,et al.  Prevalence and Costs of Chronic Conditions in the VA Health Care System , 2003, Medical care research and review : MCRR.

[18]  M. Gold,et al.  OUT-OF-POCKET HEALTH CARE EXPENSES FOR MEDICARE HMO BENEFICIARIES: ESTIMATES BY HEALTH STATUS, 1999-2001 , 2002 .

[19]  M. Gold,et al.  Medicare+Choice 1999-2001: An Analysis of Managed Care Plan Withdrawals and Trends in Benefits and Premiums , 2002 .

[20]  John A Spertus,et al.  Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. , 2002, Journal of the American College of Cardiology.

[21]  L. Leape,et al.  Comparison of Use of Medications After Acute Myocardial Infarction in the Veterans Health Administration and Medicare , 2001, Circulation.

[22]  D. Blumenthal,et al.  Description And Analysis of the Va National Formulary , 2000 .

[23]  N. Roos,et al.  Administrative data. Baby or bathwater? , 1998, Medical care.

[24]  L. Iezzoni.  Assessing Quality Using Administrative Data , 1997, Annals of Internal Medicine.

[25]  L. J. Passman,et al.  Elderly Veterans Receiving Care at a Veterans Affairs Medical Center While Enrolled in Medicare-Financed HMOs : Is the Taxpayer Paying Twice? , 1997, Journal of general internal medicine.